PHVS vs BIIB: Which Stock is Better?
Side-by-side comparison of Pharvaris Nv and Biogen Inc in 2026
PHVS
Pharvaris Nv
$28.58
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | PHVS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $1.88B | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze PHVS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHVS or BIIB a better investment?
Comparing PHVS and BIIB: Pharvaris Nv has a market cap of $1.88B while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHVS and BIIB?
PHVS (Pharvaris Nv) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHVS or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHVS or BIIB?
PHVS has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: PHVS or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for PHVS.
Which is the larger company: PHVS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $1.88B for PHVS.
Should I buy PHVS or BIIB in 2026?
Both PHVS and BIIB have investment merit. PHVS trades at $28.58 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHVS and BIIB stock?
Key differences: Market Cap ($1.88B vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).